Health News Releases

February 24, 16:43

KEYRESEARCH Launches ‘Aco-Alpha’ Nutr Supplement for Kids and Sells Out on First Day

KEYRESEARCH, a prominent name in health, announced the successful launch of its new product, ‘Aco-Alpha,’ on the 24th. It has been sold out immediately thanks to overwhelming demand. This sellout high

February 23, 13:20

ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)

Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuti

February 23, 11:50

Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology

DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical tec

February 23, 11:15

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ - a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healt

February 21, 10:40

Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp

Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet

February 21, 09:40

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki

February 20, 09:17

Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing

Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million

February 19, 15:15

Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete

February 19, 11:00

Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea

Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel ther

February 18, 15:20

Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis

Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of bo

February 16, 09:30

Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the

February 14, 15:45

Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now a

February 11, 11:30

PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality

PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturi

February 06, 09:35

Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54199035&newsitemid=20250204152815&lan=en-US&anchor=Parse+Biosciences&index=1&md

February 04, 16:35

ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer

ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, R

January 31, 17:24

GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand

GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on

January 31, 15:37

IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)

Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of aest

January 31, 14:25

Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program

Ferrer has achieved Compliance Leader Verification™, the prestigious recognition granted by Ethisphere, which distinguishes the pharmaceutical company as a global leader in upholding ethical and respo

January 31, 13:12

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.takeda.com&esheet=54196039&newsitemid=20250129509380&lan=en-US&anchor=Takeda&index=1&md5=98fdda2da61995100aa6dbd136297ebe)

January 31, 09:30

Brandnew Clinic Celebrates 15th Anniversary with Exclusive Promotions and Events

Brandnew Clinic (www.brandnewclinic.com) has announced a month-long celebration in February to commemorate its 15th anniversary and express gratitude to its loyal clients. Under the leadership of Dr.

January 30, 15:50

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54191699&newsitemid=20250127274764&lan=en-US&anc

January 30, 15:35

Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines

Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight loss on the skin and the importance of factoring in aesthetic treatment goal

January 30, 11:55

ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting

ImmunoMet Therapeutics, Inc., (“ImmunoMet”, or the “Company”), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data update from t

January 24, 11:15

LTIMindtree Renews its Strategic Alliance with the Association of American Medical Colleges (AAMC)

LTIMindtree (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ltimindtree.com%2F&esheet=54183242&newsitemid=20250120318350&lan=en-US&anchor=LTIMindtree&index=1&md5=f780cd94b90cf27

January 23, 15:24

IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership

Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 - February 1 in Paris, F

News by Region

News by Industry